MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-21-0000358
Sanjar Pharma LLP - pharma in Himatnagar, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹18.75 Cr
▲ 10% YoY
Net profit · FY 2024
₹3.96 Cr
Net margin 21.1%
EBITDA · FY 2024
₹4.74 Cr
EBITDA margin 25.3%
Contribution obligation
₹4 Cr
As per LLP agreement
Open charges
₹4.52 Cr
Satisfied ₹11 Cr
LLP age
12 yrs
Est. 2014
Employees · EPFO
15
Provident fund records
Designated partners
2
As per MCA filings
About Sanjar Pharma LLP
Data last updated:
Sanjar Pharma LLP is a limited liability partnership (LLP) based in Himatnagar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 March 2014 and has been in existence for over 12 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAC-1431. Its GSTIN is 24ACQFS6814A1Z6 (Gujarat).
The LLP has a total obligation of contribution of ₹4 Cr. It is led by designated partners Mohmadazaz Mohmadyunus Mukdiwala and Mohmadmoin Khalilahmed Modasiya.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at L S No. 622/2/1/4 Dedhrota, Himatnagar, Gujarat, India – 383001.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹18.75 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹3.96 Cr (net margin 21.1%) and EBITDA of ₹4.74 Cr (EBITDA margin 25.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 16% over five years.
The LLP has about 15 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: Sanjar Pharma. As per MCA filings, the LLP has open charges of ₹4.52 Cr and satisfied charges of ₹11 Cr on record. Court records list 1 case involving the LLP, including 1 filed by the LLP.
Sanjar Pharma LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-21-0000358). For more details, the LLP can be reached via its website sanjarpharma.com.
Company details
LLPIN AAC-1431
Incorporation Date 04 March 2014
Total Obligation of Contribution ₹4 Cr
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-GJ-21-0000358
Key People
Mohmadazaz Mohmadyunus Mukdiwala Designated Partner Mohmadmoin Khalilahmed Modasiya Designated Partner Recognitions & Rankings of Sanjar Pharma
Contact details
Sanjar Pharma LLP's registered office is in Himatnagar, Gujarat. Its website is sanjarpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressL S No. 622/2/1/4 Dedhrota, Himatnagar, Gujarat, India – 383001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sanjar Pharma LLP, buy the company report.
Comprehensive company report
Sanjar Pharma LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sanjar Pharma operates one associated brand: Sanjar Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Injection manufacturing and pharmaceutical services in India. | sanjarpharma.com |
Financials of Sanjar Pharma LLP
FY 2025 filings availableSanjar Pharma LLP reported revenue of ₹18.75 Cr (up 10% YoY) for FY 2024.
Revenue · FY 2024
₹18.75 Cr ▲ 10%
Net profit · FY 2024
₹3.96 Cr margin 21.1%
EBITDA · FY 2024
₹4.74 Cr margin 25.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 10%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 41%
3 years · compounded
▼ 2%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 10% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹18.75 Cr | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹3.96 Cr | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 21.1% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Sanjar Pharma LLP, buy the company report.
Designated partners of Sanjar Pharma LLP
Sanjar Pharma has 2 current designated partners and 8 former designated partners. Current designated partners are listed first, with their designation and appointment date.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohmadazaz Mohmadyunus Mukdiwala Also directs: Sanjar Oral Care LLP | Designated Partner | 04 Mar 2014 | 12 Years 7 Months | Current |
| Mohmadmoin Khalilahmed Modasiya | Designated Partner | 04 Mar 2014 | 12 Years 7 Months | Current |
Charges & borrowings
Open charges
₹4.52 Cr
Satisfied charges
₹11 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 May 2018 | 100184517 | Axis Bank Limited | ₹4.52 Cr | Open | |
| 24 Nov 2015 | 100016120 | Dena Bank | ₹11 Cr | Satisfied |
To see the full charge records of Sanjar Pharma LLP, buy the company report.
Total charge records: 2 View all charges
Legal cases
Sanjar Pharma LLP has 1 court case on record: 1 filed by Sanjar Pharma. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sabarkantha at Himmatnagar, Gujarat | Criminal complaint | Filed by the company against Layaka B.D.R.International Ltd. | Disposed |
To see the full case history of Sanjar Pharma LLP, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanjar Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sanjar Pharma LLP has a workforce of 15 employees on its EPFO records as of Mar 25, 2025, across 1 active EPFO establishment.
Employee count
15
Active EPFO establishments
1
GST
Sanjar Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ACQFS6814A1Z6 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sanjar Pharma LLP, buy the company report.
Recent activity
Sanjar Pharma LLP has 10 designated partner changes on record since 2014: 8 appointments and 2 cessations. The latest: Mohmadzuber Abdulrazzaq Harsoliya ceased to be Partner on 21 Mar 2018.
AGM
Sanjar Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Sanjar Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Axis Bank Limited of Rs. 4.52 Cr registered on 23 May 2018 with Charge ID 100184517 was modified on 04 May 2023.
Charges
A charge registered on 24 Nov 2015 via Charge ID 100016120 with Dena Bank was fully satisfied on 07 Jul 2018.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.52 Cr with Charge ID 100184517 was registered on 23 May 2018.
Ceased
Mohmadzuber Abdulrazzaq Harsoliya ceased to be Partner.
Charges
A charge with Dena Bank amounted to Rs. 11.00 Cr with Charge ID 100016120 was registered on 24 Nov 2015.
Appointed
Movazid Nizamuddin Bhurawala was appointed as Partner.
Appointed
Nizamuddin Abdulaziz Bhurawala was appointed as Partner.
Appointed
Shahidhusain Akadar Harsolia was appointed as Partner.
Ceased
Sirinbanu Shahid Husain Harsolia ceased to be Partner.
Appointed
Zahiruddin Nizamuddin Bhurawala was appointed as Partner.
5 earlier events are in the company report.
Frequently asked questions
Sanjar Pharma is an active limited liability partnership based in Himatnagar, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 04 March 2014 (12+ years old) and is registered under LLPIN AAC-1431.
Sanjar Pharma has 2 current designated partners:
- Mohmadazaz Mohmadyunus Mukdiwala - Designated Partner
- Mohmadmoin Khalilahmed Modasiya - Designated Partner
The latest financial statements of Sanjar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sanjar Pharma is 24ACQFS6814A1Z6, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Sanjar Pharma is AAC-1431. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Sanjar Pharma has 1 court case on record: 1 filed by the LLP.
Sanjar Pharma was incorporated on 04 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Mohmadzuber Abdulrazzaq Harsoliya ceased to be Partner on 21 Mar 2018. Movazid Nizamuddin Bhurawala was appointed as Partner on 02 Dec 2014. Nizamuddin Abdulaziz Bhurawala was appointed as Partner on 02 Dec 2014. Sanjar Pharma has 10 designated partner changes on record in total.
Yes, Sanjar Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-21-0000358).
Sanjar Pharma can be reached through the website sanjarpharma.com. Its registered office is in Himatnagar, Gujarat, India.